EC Number |
Recommended Name |
Source Tissue |
Reference |
---|
1.1.1.218 | morphine 6-dehydrogenase |
bile |
- |
-, 286287 |
2.3.2.2 | gamma-glutamyltransferase |
bile |
- |
487906, 487942, 487949, 737142 |
3.1.1.47 | 1-alkyl-2-acetylglycerophosphocholine esterase |
bile |
- |
650326, 80955 |
3.1.4.12 | sphingomyelin phosphodiesterase |
bile |
- |
135179, 664216 |
3.2.1.31 | beta-glucuronidase |
bile |
- |
26870 |
3.4.11.2 | membrane alanyl aminopeptidase |
bile |
- |
701354 |
3.4.19.9 | folate gamma-glutamyl hydrolase |
bile |
- |
647302, 683802 |
3.5.1.24 | choloylglycine hydrolase |
bile |
- |
670898 |
3.6.1.9 | nucleotide diphosphatase |
bile |
- |
733574 |
3.4.21.47 | alternative-complement-pathway C3/C5 convertase |
bile |
contains factor B |
36601 |
1.14.14.73 | albendazole monooxygenase (sulfoxide-forming) |
bile |
in bile of albendazole-treated animals, only albendazole S-oxide, but not the sulfone, is present |
745602 |
1.10.5.1 | ribosyldihydronicotinamide dehydrogenase (quinone) |
bile |
no significant difference in expression in normal and malignant biliary tissue. Activity of NQO2 is significatly lower than in hepatocellular tissue |
659967 |
1.14.11.16 | peptide-aspartate beta-dioxygenase |
bile |
proliferating ducts |
439252 |